Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Journal of Immunotherapy and Precision Oncology
|
June 27, 2022
Immune Checkpoint Blockade in Gastrointestinal Cancers: The Current Status and Emerging Paradigms
Mihailo Miljanic, Anna Capasso, Todd A Triplett, et al.
European Journal of Immunology
|
May 16, 2012
Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG
Todd A Triplett, Brendan D Curti, Peter R Bonafede, et al.
BMC Cancer
|
April 30, 2020
Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+ breast cancer
Meghan J Bloom, Angela M Jarrett, Todd A Triplett, et al.
Cancer Immunology Research
|
January 29, 2015
STAT3 Signaling Is Required for Optimal Regression of Large Established Tumors in Mice Treated with Anti-OX40 and TGFβ Receptor Blockade
Todd A Triplett, Christopher G Tucker, Kendra C Triplett, et al.
Multiple Sclerosis and Related Disorders
|
October 12, 2022
Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy
Sam A Bazzi, Cole Maguire, Nisha Holay, et al.
Addiction Biology
|
March 17, 2020
Microglia depletion and alcohol: Transcriptome and behavioral profiles
Anna S Warden, Todd A Triplett, Aram Lyu, et al.
Frontiers in Immunology
|
September 25, 2023
Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy
Nisha Holay, Alexander Somma, Mark Duchow, et al.
Blood
|
August 27, 2020
Tumor-associated myeloid cells provide critical support for T-ALL
Aram Lyu, Todd A Triplett, Seo Hee Nam, et al.
Journal for Immunotherapy of Cancer
|
July 3, 2023
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies
Kristin G Anderson, David A Braun, Aitziber Buqué, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 11, 2016
Endogenous dendritic cells from the tumor microenvironment support T-ALL growth via IGF1R activation
Todd A Triplett, Kim T Cardenas, Jessica N Lancaster, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Journal of Immunotherapy and Precision Oncology
|
June 27, 2022
Immune Checkpoint Blockade in Gastrointestinal Cancers: The Current Status and Emerging Paradigms
Mihailo Miljanic, Anna Capasso, Todd A Triplett, et al.
European Journal of Immunology
|
May 16, 2012
Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG
Todd A Triplett, Brendan D Curti, Peter R Bonafede, et al.
BMC Cancer
|
April 30, 2020
Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+ breast cancer
Meghan J Bloom, Angela M Jarrett, Todd A Triplett, et al.
Cancer Immunology Research
|
January 29, 2015
STAT3 Signaling Is Required for Optimal Regression of Large Established Tumors in Mice Treated with Anti-OX40 and TGFβ Receptor Blockade
Todd A Triplett, Christopher G Tucker, Kendra C Triplett, et al.
Multiple Sclerosis and Related Disorders
|
October 12, 2022
Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy
Sam A Bazzi, Cole Maguire, Nisha Holay, et al.
Addiction Biology
|
March 17, 2020
Microglia depletion and alcohol: Transcriptome and behavioral profiles
Anna S Warden, Todd A Triplett, Aram Lyu, et al.
Frontiers in Immunology
|
September 25, 2023
Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy
Nisha Holay, Alexander Somma, Mark Duchow, et al.
Blood
|
August 27, 2020
Tumor-associated myeloid cells provide critical support for T-ALL
Aram Lyu, Todd A Triplett, Seo Hee Nam, et al.
Journal for Immunotherapy of Cancer
|
July 3, 2023
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies
Kristin G Anderson, David A Braun, Aitziber Buqué, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 11, 2016
Endogenous dendritic cells from the tumor microenvironment support T-ALL growth via IGF1R activation
Todd A Triplett, Kim T Cardenas, Jessica N Lancaster, et al.
Page
of 2